GoodRx sells shares in IPO above target range

© Reuters.

NEW YORK (Reuters) – GoodRx Holdings Inc (O:) on Tuesday priced its initial public offering (IPO) at $33 per share, above its target range, according to a person familiar with the matter.

The U.S. online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.

GoodRx did not immediately respond to a request for comment.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.